intravitreal injection
Showing 1 - 25 of >10,000
Pain, Intravitreal Injection, Pain, Acute Trial in Canada, United States (Use of bromfenac 0.09% to reduce intravitreal
Recruiting
- Pain
- +2 more
- Use of bromfenac 0.09% to reduce intravitreal injection pain
- Use of artificial tears to reduce intravitreal injection pain
-
Boston, Massachusetts
- +4 more
Nov 8, 2023
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Beijing (Intravitreal injection of IBI302(dose 1),
Suspended
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- Intravitreal injection of IBI302(dose 1)
- +3 more
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jul 17, 2023
Intravitreal Injection Site and Perceived Pain
Recruiting
- Pain
- Intravitreal injection site
-
Galveston, TexasUniversity of Texas Medical Branch
Jan 19, 2023
Diabetic Macular Edema, Pars Plana Vitrectomy, Conbercept Trial in Tianjin (Vitrectomy combined with ILM peeling, Conbercept
Not yet recruiting
- Diabetic Macular Edema
- +2 more
- Vitrectomy combined with ILM peeling
- Conbercept intravitreal injection
-
Tianjin, Tianjin, ChinaTianjin medical university eye hosipital
Feb 14, 2023
Study in Subjects Who Received vMCO-I Administered Via
Enrolling by invitation
- Retinitis Pigmentosa
- +2 more
- Gene Therapy product:vMCO-I
-
Cuttack, Odisha, IndiaJPM Rotary Club of Cuttack Eye Hospital and Research Institute
Jun 26, 2023
Age-Related Macular Degeneration Trial in Malvern, Saint Albans (BBC1501)
Not yet recruiting
- Age-Related Macular Degeneration
-
Malvern, Victoria, Australia
- +1 more
Apr 5, 2023
Primary Vitreoretinal Lymphoma Trial in Beijing (Intravitreal injection of methotrexate)
Recruiting
- Primary Vitreoretinal Lymphoma
- Intravitreal injection of methotrexate
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 11, 2023
Stargardt Disease Trial in Miami, McAllen (Gene Therapy-vMCO-010)
Active, not recruiting
- Stargardt Disease
- Gene Therapy-vMCO-010
-
Miami, Florida
- +1 more
Nov 28, 2022
Age-Related Macular Degeneration Trial (Loteprednol Etabonate Ophthalmic Gel [Lotemax], Nepafenac Ophthalmic 0.3% Ophthalmic
Not yet recruiting
- Age-Related Macular Degeneration
- Loteprednol Etabonate Ophthalmic Gel [Lotemax]
- +2 more
- (no location specified)
Sep 14, 2022
Exudative Age-related Macular Degeneration Trial (intravitreal injection)
Completed
- Exudative Age-related Macular Degeneration
- intravitreal injection
- (no location specified)
Apr 19, 2022
Diabetic Macular Edema Trial (FARICIMAB 6 Mg in 0.05 mL INTRAVITREAL INJECTION, SOLUTION [VABYSMO])
Not yet recruiting
- Diabetic Macular Edema
- FARICIMAB 6 Mg in 0.05 mL INTRAVITREAL INJECTION, SOLUTION [VABYSMO]
- (no location specified)
Nov 3, 2022
Diabete Type 2, Cataract, Triamcinolone Acetonide Trial in Damascus (Triamcinolone Acetonide)
Completed
- Diabete Type 2
- +3 more
- Triamcinolone Acetonide
-
Damascus, Syrian Arab RepublicDamascus University
Oct 21, 2022
To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD Trial (LX109)
Not yet recruiting
- To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD
- (no location specified)
Sep 1, 2023
Intravitreal Injection, Ocular Rinse, Age-Related Macular Degeneration Trial in Oklahoma City (OSDI questionnaire, SPEEDII
Completed
- Intravitreal Injection
- +4 more
- OSDI questionnaire
- SPEEDII questionnaire
-
Oklahoma City, OklahomaDean McGee Eye Institute
Nov 7, 2022
Dry Age-related Macular Degeneration Trial in Rome (Intravitreal injection of CB-PRP)
Recruiting
- Dry Age-related Macular Degeneration
- Intravitreal injection of CB-PRP
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023
Macular Edema Trial in Tehran (intravitreal injection of bevacizumab with acetazolamide tablets, intravitreal injection of
Active, not recruiting
- Macular Edema
- intravitreal injection of bevacizumab with acetazolamide tablets
- intravitreal injection of bevacizumab
-
Tehran, Iran, Islamic Republic ofOphthalmic Research center
Mar 12, 2022
Wet Age-related Macular Degeneration Trial (Ranibizumab, SCT510A)
Not yet recruiting
- Wet Age-related Macular Degeneration
- (no location specified)
Jul 28, 2022
Intravitreal Injection, Pain, Subconjunctival Hemorrhage Trial in Holon (Cooled eye drops and povidone-iodine)
Completed
- Intravitreal Injection
- +2 more
- Cooled eye drops and povidone-iodine
-
Holon, Hamerkaz, IsraelWolfson Medical Center
Dec 28, 2021
Retinitis Pigmentosa Trial in Irvine, Los Angeles, Boston (human retinal progenitor cells)
Completed
- Retinitis Pigmentosa
- human retinal progenitor cells
-
Irvine, California
- +2 more
Aug 8, 2022
Diabetic Macular Edema Trial in Cairo (intra-vitreal injection of Ranibizumab, anterior chamber paracentesis)
Recruiting
- Diabetic Macular Edema
- intra-vitreal injection of Ranibizumab
- anterior chamber paracentesis
-
Cairo, EgyptAin shams university
May 15, 2023
Glaucoma, Neovascular, Vascular Endothelial Growth Factor Overexpression Trial in Hat-yai (Intracameral injection, Intravitreal
Recruiting
- Glaucoma, Neovascular
- Vascular Endothelial Growth Factor Overexpression
- Intracameral injection
- Intravitreal injection
-
Hat-yai, Songkhla, ThailandGlaucoma unit , Department of Ophthalmology Faculty of Medicine
Feb 3, 2022
Diabetic Macular Edema Trial (RC-28E, Aflibercept)
Not yet recruiting
- Diabetic Macular Edema
- RC-28E
- Aflibercept
- (no location specified)
May 30, 2023
Focal Laser Single Intravitreal Ranibizumab Retinal Artery
Completed
- Retinal Artery Macroaneurysm
- Dual focal laser and intravitreal Ranibizumab injection
-
Cairo, EgyptKasr alainy faculty of medicine
Jan 29, 2023
Retinitis Pigmentosa Trial in Irvine, Los Angeles, Boston (human retinal progenitor cells, Mock injection)
Completed
- Retinitis Pigmentosa
- human retinal progenitor cells
- Mock injection
-
Irvine, California
- +2 more
Mar 3, 2022